Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jakub Hustý is active.

Publication


Featured researches published by Jakub Hustý.


Annals of Hepatology | 2018

Mucinous cystic neoplasm of the liver or intraductal papillary mucinous neoplasm of the bile duct? A case report and a review of literature

Lumír Kunovský; Zdeněk Kala; Roman Svatoň; Petr Moravčík; Jan Mazanec; Jakub Hustý; Vladimír Procházka

Mucinous cystic neoplasm of the liver (MCN-L) and intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) are diagnoses that were classified by the World Health Organization in 2010 as mucin-producing bile duct tumors of the hepatobiliary system. The preoperative differential diagnosis between these two entities is difficult; the presence of a communication with the bile duct is usually considered as a typical sign of IPMN-B. However, the presence of an ovarian-like stroma (OLS) has been established to define the diagnosis of MCN-L. We present the case of a 33-year-old woman with a rapid progression of a cystic tumor of the liver. In 2 years, the lesion increased from 27 to 64 mm and a dilation of the left hepatic duct appeared. Percutaneous transhepatic drainage with a biopsy was performed. No malignant cells were found on biopsy. Because of the rapid progression of the cystic tumor and unclear malignant potential, left hemihepatectomy was performed. Even though tumor masses were present in the biliary duct, on the basis of the presence of OLS, histology finally confirmed MCN-L with intermediate-grade intraepithelial dysplasia to high-grade intraepithelial dysplasia. The patient is currently under oncologic follow-up with no signs of recurrence of the disease. We present a rare case where MCN-L caused a dilation of the left hepatic duct, a sign that is usually a characteristic of IPMN-B.Mucinous cystic neoplasm of the liver (MCN-L) and intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) are diagnoses that were classified by the World Health Organization in 2010 as mucin-producing bile duct tumors of the hepatobiliary system. The preoperative differential diagnosis between these two entities is difficult; the presence of a communication with the bile duct is usually considered as a typical sign of IPMN-B. However, the presence of an ovarian-like stroma (OLS) has been established to define the diagnosis of MCN-L. We present the case of a 33-year-old woman with a rapid progression of a cystic tumor of the liver. In 2 years, the lesion increased from 27 to 64 mm and a dilation of the left hepatic duct appeared. Percutaneous transhepatic drainage with a biopsy was performed. No malignant cells were found on biopsy. Because of the rapid progression of the cystic tumor and unclear malignant potential, left hemihepatectomy was performed. Even though tumor masses were present in the biliary duct, on the basis of the presence of OLS, histology finally confirmed MCN-L with intermediate-grade intraepithelial dysplasia to high-grade intraepithelial dysplasia. The patient is currently under oncologic follow-up with no signs of recurrence of the disease. We present a rare case where MCN-L caused a dilation of the left hepatic duct, a sign that is usually a characteristic of IPMN-B.


European Journal of Radiology | 2009

Crohn's disease: clinical-surgical questions and imaging answers.

Vlastimil Válek; Jakub Hustý


Archive | 2018

Prevention of benign stenosis due to endoluminal irreversibleelectroporation in bile ducts

Tomáš Andrašina; Jiří Pánek; Dalibor Cervinka; Iva Svobodová; Tomáš Rohan; Jakub Hustý; Hiroko Martin; Vlastimil Válek


Archive | 2017

EP-07 Mnohočetné postižení tenkého střeva neuroendokrinním tumorem - kazuistika

Lumír Kunovský; Milan Dastych; Oldřich Robek; Jakub Vlažný; Jakub Hustý; Michal Eid; Karolina Poredská; Jiří Dolina; Zdeněk Kala


Archive | 2017

VOLUMETRIE JATER PŘED A PO EMBOLIZACI V. PORTAE - NAŠE ZKUŠENOSTI

Monika Staňková; Vendula Trunčíková; Tomáš Andrašina; Jakub Hustý; Vlastimil Válek


Archive | 2016

Contrast enhanced ultrasound in patients with Crohn´s disease

Jakub Hustý; Vlastimil Válek; Daniel Bartušek; Miriama Šmajerová; Lucie Prokopová


Archive | 2016

Uzavírací zařízení Mynx a Exoseal – naše zkušenosti

Jakub Hustý; Jaroslav Boudný; Daniel Bartušek; Jiří Pánek; Jan Chaloupka


Archive | 2016

Perkutánní biopsie ze žlučových cest

Tomáš Andrašina; Tomáš Rohan; Jakub Hustý; Jiří Pánek; Vlastimil Válek


Archive | 2016

Krvácení a intervenční radiolog

Jakub Hustý; Jaroslav Boudný


Česká radiologie | 2015

Transarteriální chemoembolizace jater - Technické problémy akomplikace výkonu

Jakub Hustý; Jaroslav Boudný; Vlastimil Válek; Tomáš Andrašina

Collaboration


Dive into the Jakub Hustý's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dalibor Cervinka

Brno University of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge